Content
The Vicious Cycle Approaches
Video By:
Adam Taggart
Watch
Monday, December 25, 2017 12:34 PM EDT
You can be thrilled about the fact your 401K has appreciated -- but it's sitting on a pocket of air because nothing is improved underneath the surface.
In this video: GLD
Biotech Year One: A Year Of Trials Tribulations And Discovery
Article By:
Kieran O'Dea
Read
Monday, December 25, 2017 8:24 AM EDT
The biotech market is its own beast, derived from the aggregate opinions and knowledge of the mainstream thought. The market has a binary, linear, and simplistic approach to trial results ignoring the context in which each trial is conducted.
2017 Total Return Performance By Asset Class Using Key ETFs
Article By:
Bespoke Investment Group
Read
Monday, December 25, 2017 5:44 AM EDT
The Consumer Discretionary ETF (XLY) is up more than any other ETF during the bull market with a total return of 604%. The Nasdaq 100 (QQQ) is up second most at +570%.
Season’s Greetings
Article By:
Acting Man
Read
Monday, December 25, 2017 4:50 AM EDT
The rapid bubble-like advance this year has triggered a lot of debate, with supporters and detractors of crypto-currencies alike appearing to become more strident and zealous in making their case.
In this article: BITCOMP
Fannie Mae Most Profitable Company Per Employee, Freddie #3 And Other News Of The Week
Article By:
Jeff Miller
Read
Sunday, December 24, 2017 3:30 PM EDT
The economic calendar is light, the week is short, and the A-Teams are taking some time off. It is the formula for punditry gone wild. But what will be the subject, especially if Bitcoin is not moving much?
Is The Crypto Craze Over?
Article By:
TheoTrade
Read
Sunday, December 24, 2017 1:59 PM EDT
The crash in bitcoin is starting to look like something more than the minor setback like we’ve seen in the past few weeks. When it starts to fall, it will crash like a rock. Meanwhile, the yield curve flattens and gold makes a comeback.
4 Biotech Stocks That More Than Doubled This Year
Article By:
Zacks Investment Research
Read
Saturday, December 23, 2017 7:50 PM EDT
The biotech industry has been on the comeback trail in 2017 after facing challenges including pricing pressure, rising competition, pipeline setbacks, pricing pressure, slowdown in growth of mature products and generic competition for key drugs.
The Euro Area Countries Registered Strong Growth In 2017
Article By:
Arthur Donner
Read
Friday, December 22, 2017 9:17 AM EDT
The euro area economy has performed significantly better in 2017 than one would have expected a year ago.
Hark, The Allocators Sing
Article By:
AllAboutAlpha
Read
Friday, December 22, 2017 12:50 AM EDT
As we move into 2018, alternatives managers will undoubtedly face a host of new issues and challenges in delivering to the investment community differentiated value.
Coming Housing Boom Could Mean It's Time To Add Raw Materials
Article By:
Frank Holmes
Read
Thursday, December 21, 2017 10:26 AM EDT
The last housing boom, which peaked in 2006, was accompanied by elevated commodity prices.
Did The 2017 Real Estate Market Forecast Pan Out How We Expected?
Article By:
Than Merrill
Read
Thursday, December 21, 2017 1:30 AM EDT
With the end of 2017 drawing closer to an end, now is the perfect time to take a look at the real estate market forecast many predicted for this year and determine if it unfolded the way many had expected.
2017 For The Bears
Article By:
Tim Knight
Read
Wednesday, December 20, 2017 3:18 PM EDT
This hasn’t been just a bullish year; it’s been a never-before-seen, unprecedented, all-records-broken kind of year, with things like 12 up months in a row (never happened before).